Specialty Pharmacy & Distribution

HealthBridge Pharma & Biotech - June 21, 2012
Specialty patients often face complex and costly treatments for their therapies. Nonadherence among these patients can lead to expensive and dangerous adverse health effects.  Research shows that keeping one organ transplant...
HealthBridge Pharma & Biotech - May 21, 2012
It all starts with a phone call.  And, that phone call is answered by a patient care advocate.  You see, our pharma services receive phone calls every day from patients, prescribers, and healthcare workers.  Whether...
, Vice President, Global Pharmaceutical Business Development - May 17, 2012
Pinsonault’s Managed Market Account Management Training took place this week in beautiful Bonita Springs, Florida. The conference hosted 55 attendees representing 33 different companies. This intimate training conference sparked great...
HealthBridge Pharma & Biotech - April 13, 2012
The World Orphan Drug Congress being held this week presents a unique opportunity for manufacturers, advocacy groups,  and patient access providers to meet and discuss how we can all work together to take really good care of...
HealthBridge Pharma & Biotech - April 12, 2012
For those of us connected with manufacturing or managing orphan drugs, it's easy to obsess over the numbers:  there are 7,000 designated rare diseases, but fewer than 400 approved orphan drug therapies; more than 30 million...

Pages